Alsaadi, J. H. H. (2025). Interferon-Beta-1a (Rebif) a Risk Factor on Liver, Kidney and Sex Hormones with Multiple Sclerosis Patients: A Review. American Journal of Biomedicine and Pharmacy, 2(4), 1–13. https://doi.org/10.51699/ajbp.v2i4.826